First 20 months' experience with use of metformin for type 2 diabetes in a large health maintenance organization

被引:43
作者
Selby, JV
Ettinger, B
Swain, BE
Brown, JB
机构
[1] Kaiser Permanente Med Care Program, Div Res, Oakland, CA 94611 USA
[2] Kaiser Permanente Med Care Program, Ctr Hlth Res, NW Div, Portland, OR USA
关键词
D O I
10.2337/diacare.22.1.38
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To assess adherence to prescribing guidelines, continuation rates, population effects on glycemic control, and occurrence of lactic acidosis during the first 20 months of the availability of metformin in a large health maintenance organization. RESEARCH DESIGN AND METHODS - A retrospective cohort study was performed in the 90,000-member diabetes registry of Kaiser Permanente, northern California. Principal study measures were the proportions of patients started on metformin who met prescribing guidelines (previously on sulfonylureas, HbA(1c) obesity, creatinine), the change in HbA(1c), at 6 months after starting metformin, and hospitalization rates for lactic acidosis. RESULTS - A total of 9,875 patients received metformin during this interval. At least 74% were previously treated with sulfonylureas alone, 81% had baseline HbA(1c) greater than or equal to 8.5%, 71% were obese, and 99% had a serum creatinine less than or equal to 1.5 mg/dl. Among patients on sulfonylureas at baseline, those starting metformin had significantly lower HbA(1c) levels 6 months later than those not started, alter adjustment for age, sex, and the higher baseline levels in those started (adjusted difference: 0.5%, P < 0.0001). Patients starting metformin as initial monotherapy also improved significantly, but patients previously treated with insulin (with or without sulfonylureas) had slightly higher follow-up HbA(1c) levels than similar patients not starting metformin. Continuation of metformin at 12 months was significantly higher for patients previously treated with sulfonylureas than other groups. One probable case of lactic acidosis was identified during 4,502 person-years on metformin. CONCLUSIONS - Adherence to prescribing guidelines was relatively high during metformin's first 20 months of availability. Glycemic control improved substantially for patients previously treated with sulfonylureas. Lactic acidosis was rare.
引用
收藏
页码:38 / 44
页数:7
相关论文
共 15 条
[1]  
Aviles-Santa L, 1998, DIABETES, V47, pA89
[2]   Persistence of use of lipid-lowering medications - A cross-national study [J].
Avorn, J ;
Monette, J ;
Lacour, A ;
Bohn, RL ;
Monane, M ;
Mogun, H ;
LeLorier, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1458-1462
[3]   Drug therapy - Metformin [J].
Bailey, CJ ;
Turner, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) :574-579
[4]  
Bergenstal R, 1998, DIABETES, V47, pA89
[5]   An overview of metformin in the treatment of type 2 diabetes mellitus [J].
Davidson, MB ;
Peters, AL .
AMERICAN JOURNAL OF MEDICINE, 1997, 102 (01) :99-110
[6]   EFFICACY OF METFORMIN IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
DEFRONZO, RA ;
GOODMAN, AM ;
ABELOVE, W ;
REID, E ;
PITA, J ;
CALLAHAN, M ;
JOHNSON, D ;
PELAYO, E ;
PUGH, J ;
SHANK, M ;
GARZA, P ;
HAAG, B ;
KORFF, J ;
ANGELO, A ;
IZENSTEIN, B ;
VANDERLEEDEN, M ;
CATHCART, H ;
TIERNEY, M ;
BIGGS, D ;
KARAM, J ;
NOLTE, M ;
GAVIN, L ;
ELDER, MA ;
CORBOY, J ;
THWAITE, D ;
WONG, S ;
DAVIDSON, M ;
PETERS, A ;
DUNCAN, T ;
KERCHER, S ;
FISCHER, J ;
KIPNES, M ;
RADNICK, BJ ;
ROURA, M ;
ROQUE, J ;
MONTGOMERY, C ;
COLLUM, P ;
RUST, M ;
POHL, S ;
PFEIFER, M ;
ALLWEISS, P ;
LEICHTER, S ;
LEACH, P ;
GALLINA, D ;
MUSEY, V ;
BERKOWITZ, K ;
EASTMAN, R ;
TAYLOR, T ;
DELAPENA, MS ;
ZAWADSKI, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (09) :541-549
[7]   METFORMIN FOR OBESE, INSULIN-TREATED DIABETIC-PATIENTS - IMPROVEMENT IN GLYCEMIC CONTROL AND REDUCTION OF METABOLIC RISK-FACTORS [J].
GIUGLIANO, D ;
QUATRARO, A ;
CONSOLI, G ;
MINEI, A ;
CERIELLO, A ;
DEROSA, N ;
DONOFRIO, F .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (02) :107-112
[8]  
Gueriguian J, 1996, NEW ENGL J MED, V334, P269
[9]   ANTIHYPERGLYCEMIC EFFICACY, RESPONSE PREDICTION AND DOSE-RESPONSE RELATIONS OF TREATMENT WITH METFORMIN AND SULFONYLUREA, ALONE AND IN PRIMARY COMBINATION [J].
HERMANN, LS ;
SCHERSTEN, B ;
MELANDER, A .
DIABETIC MEDICINE, 1994, 11 (10) :953-960
[10]   DISCONTINUATION OF AND CHANGES IN TREATMENT AFTER START OF NEW COURSES OF ANTIHYPERTENSIVE DRUGS - A STUDY OF A UNITED-KINGDOM POPULATION [J].
JONES, JK ;
GORKIN, L ;
LIAN, JF ;
STAFFA, JA ;
FLETCHER, AP .
BMJ-BRITISH MEDICAL JOURNAL, 1995, 311 (7000) :293-295